Form 4: LifeMD Director Joseph DiTrolio Receives Stock Grant

LifeMD, Inc. Director Joseph DiTrolio was granted 22,365 restricted shares of common stock, vesting on June 1, 2026.

Summary

• Joseph DiTrolio, a Director of LifeMD, Inc. (LFMD), acquired 22,365 shares of common stock.
• The transaction occurred on October 2, 2025, and was a grant of restricted shares.
• The acquisition price for these shares was $0.
• Following this transaction, Joseph DiTrolio beneficially owns a total of 273,413 shares of common stock.
• The granted restricted shares are scheduled to vest on June 1, 2026.

Sentiment

Score: 6

Explanation: The sentiment is mildly positive as it represents an increase in a director's beneficial ownership, aligning their interests with shareholders, and is a routine compensation event.

Positives

• The grant of restricted shares to a director increases their beneficial ownership, potentially aligning management interests with shareholder value.
• The transaction indicates continued compensation and retention of a key director.

Future Outlook

The granted restricted shares are scheduled to vest on June 1, 2026, indicating a future milestone for the director's compensation.

Industry Context

Grants of restricted stock to directors are a common form of equity compensation in publicly traded companies, used to incentivize long-term performance and align director interests with those of shareholders. This transaction is consistent with standard corporate governance practices for director compensation.

Related Party Transactions

• The grant of 22,365 restricted shares of common stock to Joseph DiTrolio, a Director of LifeMD, Inc., constitutes a related party transaction as it involves compensation from the company to a member of its board.

Stakeholder Impact

• Shareholders: The increased beneficial ownership by a director may signal stronger alignment of interests between management and shareholders.
• Employees: This transaction is specific to a director's compensation and does not directly impact the broader employee base.

Next Steps

• The restricted shares will vest on June 1, 2026, at which point they will become fully owned by the director.

Key Dates

Keywords

LifeMD, LFMD, Joseph DiTrolio, Insider Trading, Form 4, Stock Grant, Restricted Shares, Director Compensation, Beneficial Ownership